Nurse-led diuretic titration via a point-of-care urinary sodium sensor in patients with acute decompensated heart failure (EASY-HF): A single-centre, randomized, open-label study.

Acute heart failure Natriuresis Nurse‐led Point‐of‐care sensor Protocolized

Journal

European journal of heart failure
ISSN: 1879-0844
Titre abrégé: Eur J Heart Fail
Pays: England
ID NLM: 100887595

Informations de publication

Date de publication:
14 Aug 2024
Historique:
revised: 23 07 2024
received: 04 05 2024
accepted: 24 07 2024
medline: 14 8 2024
pubmed: 14 8 2024
entrez: 14 8 2024
Statut: aheadofprint

Résumé

Early evaluation of the natriuretic response is recommended to guide diuretic therapy in acute decompensated heart failure (ADHF). However, its implementation in daily practice is hampered by implementation barriers and increased time constraints. The Readily Available Urinary Sodium Analysis in Patients with Acute Decompensated Heart Failure (EASY-HF) study assessed the feasibility, efficacy and safety of a nurse-led urinary sodium-based diuretic titration protocol with the use of a point-of-care urinary sodium sensor. The EASY-HF study was a single-centre, randomized, open-label study comparing diuretic management at the treating physician's discretion as standard of care (SOC) with a nurse-led natriuresis-guided protocol in patients with ADHF. The LAQUAtwin Sodium Meter (HORIBA) was used as point-of-care sensor to measure urine sodium concentration. The primary endpoint was natriuresis after 48 h. Secondary endpoints included safety profile and user-friendliness of both the protocol and the point-of-care sensor. Sixty patients were randomized towards SOC (n = 30) versus protocolized care (n = 30). The mean age was 80 ± 8 years, 25% were women and median N-terminal pro-B-type natriuretic peptide was 4667 (2667-7709) ng/L. Natriuresis after 48 h was significantly higher in the protocolized versus SOC group (820 ± 279 vs. 657 ± 273 mmol; p = 0.027). Pre-defined safety endpoints were similar among both groups. The sensor-based protocol was evaluated as easy to use by the nursing staff, and preferred over urinary collections. A nurse-led diuretic titration protocol via a point-of-care urinary sodium sensor was feasible, safe and resulted in an increased natriuresis in ADHF compared to SOC.

Identifiants

pubmed: 39140288
doi: 10.1002/ejhf.3429
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : FWO
ID : 1SF6824N

Informations de copyright

© 2024 European Society of Cardiology.

Références

Filippatos G, Zannad F. An introduction to acute heart failure syndromes: Definition and classification. Heart Fail Rev 2007;12:87–90. https://doi.org/10.1007/s10741‐007‐9008‐3
Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Epidemiology of heart failure. Eur J Heart Fail 2020;22:1342–1356. https://doi.org/10.1002/ejhf.1858
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2022;24:4–131. https://doi.org/10.1002/ejhf.2333
Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA Guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022;145:e895–e1032. https://doi.org/10.1161/CIR.0000000000001063
Mullens W, Damman K, Harjola V, Mebazaa A, Rocca HB, Martens P, et al. The use of diuretics in heart failure with congestion – a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2019;21:137–155. https://doi.org/10.1002/ejhf.1369
Felker GM, Ellison DH, Mullens W, Cox ZL, Testani JM. Diuretic therapy for patients with heart failure: JACC state‐of‐the‐art review. J Am Coll Cardiol 2020;75:1178–1195. https://doi.org/10.1016/j.jacc.2019.12.059
Ter Maaten JM, Beldhuis IE, van der Meer P, Krikken JA, Postmus D, Coster JE, et al. Natriuresis‐guided diuretic therapy in acute heart failure: A pragmatic randomized trial. Nat Med 2023;29:2625–2632. https://doi.org/10.1038/s41591‐023‐02532‐z
Dauw J, Lelonek M, Zegri‐Reiriz I, Paredes‐Paucar CP, Zara C, George V, et al. Rationale and design of the Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure study. ESC Heart Fail 2021;8:4685–4692. https://doi.org/10.1002/ehf2.13666
Dauw J, Charaya K, Lelonek M, Zegri‐Reiriz I, Nasr S, Paredes‐Paucar CP, et al. Protocolized natriuresis‐guided decongestion improves diuretic response: The multicenter ENACT‐HF study. Circ Heart Fail 2024;17:e011105. https://doi.org/10.1161/CIRCHEARTFAILURE.123.011105
Nasab Mehrabi E, Toupchi‐Khosroshahi V, Athari SS. Relationship of atrial fibrillation and N terminal pro brain natriuretic peptide in heart failure patients. ESC Heart Fail 2023;10:3250–3257. https://doi.org/10.1002/ehf2.14542
Mullens W, Dauw J, Martens P, Verbrugge FH, Nijst P, Meekers E, et al.; ADVOR Study Group. Acetazolamide in acute decompensated heart failure with volume overload. N Engl J Med 2022;387:1185–1195. https://doi.org/10.1056/NEJMoa2203094
Mullens W, Verbrugge FH, Nijst P, Martens P, Tartaglia K, Theunissen E, et al. Rationale and design of the ADVOR (Acetazolamide in Decompensated Heart Failure with Volume Overload) trial. Eur J Heart Fail 2018;20:1591–1600. https://doi.org/10.1002/ejhf.1307
HORIBA. LAQUAtwin Na‐11. https://www.horiba.com/int/water‐quality/products/detail/action/show/Product/laquatwin‐na‐11‐796 (Accessed 30 July 2024).
Meekers E, Mullens W. Spot urinary sodium measurements: The future direction of the treatment and follow‐up of patients with heart failure. Curr Heart Fail Rep 2023;20:88–100. https://doi.org/10.1007/s11897‐023‐00591‐4
Luk A, Groarke JD, Desai AS, Mahmood SS, Gopal DM, Joyce E, et al. First spot urine sodium after initial diuretic identifies patients at high risk for adverse outcome after heart failure hospitalization. Am Heart J 2018;203:95–100. https://doi.org/10.1016/j.ahj.2018.01.013
Cunningham J, Sun J, Mc Causland F, Ly S, Anstrom K, Lindenfeld J, et al. Lower urine sodium predicts longer length of stay in acute heart failure patients: Insights from the ROSE AHF trial. Clin Cardiol 2020;43:43–49. https://doi.org/10.1002/clc.23286
Collins SP, Jenkins CA, Baughman A, Miller KF, Storrow AB, Han JH, et al. Early urine electrolyte patterns in patients with acute heart failure. ESC Heart Fail 2019;6:80–88. https://doi.org/10.1002/ehf2.12368
Caravaca Perez P, Nuche J, Moran Fernandez L, Lora D, Blazquez‐Bermejo Z, Lopez‐Azor JC, et al. Potential role of natriuretic response to furosemide stress test during acute heart failure. Circ Heart Fail 2021;14:e008166. https://doi.org/10.1161/CIRCHEARTFAILURE.120.008166
Ter Maaten JM, Beldhuis IE, van der Meer P, Krikken JA, Coster JE, Nieuwland W, et al. Natriuresis‐guided therapy in acute heart failure: Rationale and design of the Pragmatic Urinary Sodium‐based treatment algoritHm in Acute Heart Failure (PUSH‐AHF) trial. Eur J Heart Fail 2022;24:385–392. https://doi.org/10.1002/ejhf.2385
Rao VS, Ivey‐Miranda JB, Cox ZL, Riello R, Griffin M, Fleming J, et al. Natriuretic equation to predict loop diuretic response in patients with heart failure. J Am Coll Cardiol 2021;77:695–708. https://doi.org/10.1016/j.jacc.2020.12.022
Meegan G, Sangkachand P, O'Brien M, Riello R, Soucier R, Jacoby D, et al. Safety and efficacy of an automated nurse‐driven diuretic titration protocol: The Yale diuretic pathway. J Card Fail 2020;26:S22. https://doi.org/10.1016/j.cardfail.2020.09.070
Tsutsui H, Albert NM, Coats AJS, Anker SD, Bayes‐Genis A, Butler J, et al. Natriuretic peptides: Role in the diagnosis and management of heart failure: A scientific statement from the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society. Eur J Heart Fail 2023;25:616–631. https://doi.org/10.1002/ejhf.2848

Auteurs

Evelyne Meekers (E)

Department of Cardiology, Ziekenhuis Oost-Limburg A.V, Genk, Belgium.
Faculty of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium.

Pieter Martens (P)

Department of Cardiology, Ziekenhuis Oost-Limburg A.V, Genk, Belgium.

Jeroen Dauw (J)

Faculty of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium.
Cardiovascular Center Aalst, OLV Hospital, Aalst, Belgium.

Henri Gruwez (H)

Department of Cardiology, Ziekenhuis Oost-Limburg A.V, Genk, Belgium.
Faculty of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium.

Sebastiaan Dhont (S)

Department of Cardiology, Ziekenhuis Oost-Limburg A.V, Genk, Belgium.
Faculty of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium.

Petra Nijst (P)

Department of Cardiology, Ziekenhuis Oost-Limburg A.V, Genk, Belgium.

Frederik H Verbrugge (FH)

Centre for Cardiovascular Diseases, University Hospital Brussels, Jette, Belgium.
Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Jette, Belgium.

Koen Ameloot (K)

Department of Cardiology, Ziekenhuis Oost-Limburg A.V, Genk, Belgium.

David Verhaert (D)

Department of Cardiology, Ziekenhuis Oost-Limburg A.V, Genk, Belgium.

Matthias Dupont (M)

Department of Cardiology, Ziekenhuis Oost-Limburg A.V, Genk, Belgium.

Jorien Stassen (J)

Nursing staff, Department of Cardiology, Ziekenhuis Oost-Limburg A.V, Genk, Belgium.

Marleen Opdenacker (M)

Nursing staff, Department of Cardiology, Ziekenhuis Oost-Limburg A.V, Genk, Belgium.

Stefan Janssens (S)

Department of Cardiology, University Hospital Leuven, Leuven, Belgium.
Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium.

Wilfried Mullens (W)

Department of Cardiology, Ziekenhuis Oost-Limburg A.V, Genk, Belgium.
Faculty of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium.

Classifications MeSH